| Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine) WH Organization World Health Organization, 2021 | 1070* | 2021 |
| Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis WH Organization World Health Organization, 2018 | 655* | 2018 |
| The global prevalence of latent tuberculosis: a systematic review and meta-analysis A Cohen, VD Mathiasen, T Schön, C Wejse European Respiratory Journal 54 (3), 2019 | 543 | 2019 |
| Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis D Elias, H Akuffo, A Pawlowski, M Haile, T Schön, S Britton Vaccine 23 (11), 1326-1334, 2005 | 238 | 2005 |
| Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives T Schön, P Miotto, CU Köser, M Viveiros, E Böttger, E Cambau Clinical Microbiology and Infection 23 (3), 154-160, 2017 | 229 | 2017 |
| Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review VN Dahl, M Mølhave, A Fløe, J van Ingen, T Schön, T Lillebaek, ... International Journal of Infectious Diseases 125, 120-131, 2022 | 174 | 2022 |
| Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis K Ängeby, P Juréen, G Kahlmeter, SE Hoffner, T Schön Bulletin of the World Health Organization 90, 693-698, 2012 | 147 | 2012 |
| Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis T Schön, P Juréen, CG Giske, E Chryssanthou, E Sturegård, J Werngren, ... Journal of antimicrobial chemotherapy 64 (4), 786-793, 2009 | 146 | 2009 |
| What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis J Heyckendorf, S Andres, CU Köser, ID Olaru, T Schön, E Sturegård, ... Antimicrobial agents and chemotherapy 62 (2), 10.1128/aac. 01550-17, 2018 | 132 | 2018 |
| Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid … TT Balcha, E Sturegård, N Winqvist, S Skogmar, A Reepalu, ZH Jemal, ... PloS one 9 (1), e85478, 2014 | 105 | 2014 |
| Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis T Schön, D Elias, F Moges, E Melese, T Tessema, O Stendahl, S Britton, ... European Respiratory Journal 21 (3), 483-488, 2003 | 100 | 2003 |
| Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates–the EUCAST broth microdilution reference method for MIC determination T Schön, J Werngren, D Machado, E Borroni, M Wijkander, G Lina, ... Clinical Microbiology and Infection 26 (11), 1488-1492, 2020 | 98 | 2020 |
| Management of patients with multidrug-resistant tuberculosis C Lange, RE Aarnoutse, JWC Alffenaar, G Bothamley, F Brinkmann, ... The international journal of tuberculosis and lung disease 23 (6), 645-662, 2019 | 96 | 2019 |
| Expression of inducible nitric oxide synthase and nitrotyrosineduring the evolution of experimental pulmonary tuberculosis R Hernandez-Pando, T Schön, EH Orozco, J Serafin, I Estrada-Garcia Experimental and Toxicologic Pathology 53 (4), 257-265, 2001 | 92 | 2001 |
| Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex M Merker, TA Kohl, I Barilar, S Andres, PW Fowler, E Chryssanthou, ... Genome Medicine 12, 1-8, 2020 | 86 | 2020 |
| The impact of asymptomatic helminth co-infection in patients with newly diagnosed tuberculosis in north-west Ethiopia E Abate, M Belayneh, A Gelaw, J Idh, A Getachew, S Alemu, E Diro, ... Public Library of Science 7 (8), e42901, 2012 | 86 | 2012 |
| Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene … J Werngren, E Sturegård, P Juréen, K Ängeby, S Hoffner, T Schön Antimicrobial Agents and Chemotherapy 56 (3), 1253-1257, 2012 | 84 | 2012 |
| Local production of nitric oxide in patients with tuberculosis T Schön, G Elmberger, Y Negesse, R Hernandez Pando, T Sundqvist, ... The International Journal of Tuberculosis and Lung Disease 8 (9), 1134-1137, 2004 | 76 | 2004 |
| Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available … KA Ängeby, P Jureen, CG Giske, E Chryssanthou, E Sturegård, ... Journal of antimicrobial chemotherapy 65 (5), 946-952, 2010 | 72 | 2010 |
| d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal D Deshpande, JWC Alffenaar, CU Köser, K Dheda, ML Chapagain, ... Clinical Infectious Diseases 67 (suppl_3), S308-S316, 2018 | 71 | 2018 |
